These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 16644732)

  • 1. Identification of a co-repressor that inhibits the transcriptional and growth-arrest activities of CCAAT/enhancer-binding protein alpha.
    McFie PJ; Wang GL; Timchenko NA; Wilson HL; Hu X; Roesler WJ
    J Biol Chem; 2006 Jun; 281(26):18069-80. PubMed ID: 16644732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCAAT/enhancer binding protein alpha binds to the Epstein-Barr virus (EBV) ZTA protein through oligomeric interactions and contributes to cooperative transcriptional activation of the ZTA promoter through direct binding to the ZII and ZIIIB motifs during induction of the EBV lytic cycle.
    Wu FY; Wang SE; Chen H; Wang L; Hayward SD; Hayward GS
    J Virol; 2004 May; 78(9):4847-65. PubMed ID: 15078966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCAAT/enhancer-binding protein-alpha is induced during the early stages of Kaposi's sarcoma-associated herpesvirus (KSHV) lytic cycle reactivation and together with the KSHV replication and transcription activator (RTA) cooperatively stimulates the viral RTA, MTA, and PAN promoters.
    Wang SE; Wu FY; Yu Y; Hayward GS
    J Virol; 2003 Sep; 77(17):9590-612. PubMed ID: 12915572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of CCAAT/enhancer-binding protein alpha (C/EBPalpha) in activation of the Kaposi's sarcoma-associated herpesvirus (KSHV) lytic-cycle replication-associated protein (RAP) promoter in cooperation with the KSHV replication and transcription activator (RTA) and RAP.
    Wang SE; Wu FY; Fujimuro M; Zong J; Hayward SD; Hayward GS
    J Virol; 2003 Jan; 77(1):600-23. PubMed ID: 12477864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear redistribution of TCERG1 is required for its ability to inhibit the transcriptional and anti-proliferative activities of C/EBPalpha.
    Banman SL; McFie PJ; Wilson HL; Roesler WJ
    J Cell Biochem; 2010 Jan; 109(1):140-51. PubMed ID: 19911371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p300 coactivates the adipogenic transcription factor CCAAT/enhancer-binding protein alpha.
    Erickson RL; Hemati N; Ross SE; MacDougald OA
    J Biol Chem; 2001 May; 276(19):16348-55. PubMed ID: 11340085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C/EBPα inhibits hepatocellular carcinoma by reducing Notch3/Hes1/p27 cascades.
    Shi YC; Zhao H; Yin C; Zeng X; Zhang Q; Xu WP; Wei J; Chen F; Xie WF
    Dig Liver Dis; 2013 Oct; 45(10):844-51. PubMed ID: 23816696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCAAT/enhancer binding protein alpha interacts with ZTA and mediates ZTA-induced p21(CIP-1) accumulation and G(1) cell cycle arrest during the Epstein-Barr virus lytic cycle.
    Wu FY; Chen H; Wang SE; ApRhys CM; Liao G; Fujimuro M; Farrell CJ; Huang J; Hayward SD; Hayward GS
    J Virol; 2003 Jan; 77(2):1481-500. PubMed ID: 12502863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A positive regulatory domain in CCAAT/enhancer binding protein β (C/EBPΒ) is required for the glucocorticoid-mediated displacement of histone deacetylase 1 (HDAC1) from the C/ebpα promoter and maximum adipogenesis.
    Abdou HS; Atlas E; Haché RJ
    Endocrinology; 2013 Apr; 154(4):1454-64. PubMed ID: 23456364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-talk between regulators of myeloid development: C/EBPalpha binds and activates the promoter of the PU.1 gene.
    Kummalue T; Friedman AD
    J Leukoc Biol; 2003 Sep; 74(3):464-70. PubMed ID: 12949251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The CCAAT enhancer-binding protein-alpha negatively regulates the transactivation of androgen receptor in prostate cancer cells.
    Chattopadhyay S; Gong EY; Hwang M; Park E; Lee HJ; Hong CY; Choi HS; Cheong JH; Kwon HB; Lee K
    Mol Endocrinol; 2006 May; 20(5):984-95. PubMed ID: 16455820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C/EBPalpha and HNF6 protein complex formation stimulates HNF6-dependent transcription by CBP coactivator recruitment in HepG2 cells.
    Yoshida Y; Hughes DE; Rausa FM; Kim IM; Tan Y; Darlington GJ; Costa RH
    Hepatology; 2006 Feb; 43(2):276-86. PubMed ID: 16440369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional regulation of the human hepatic CYP3A4: identification of a new distal enhancer region responsive to CCAAT/enhancer-binding protein beta isoforms (liver activating protein and liver inhibitory protein).
    Martínez-Jiménez CP; Gómez-Lechón MJ; Castell JV; Jover R
    Mol Pharmacol; 2005 Jun; 67(6):2088-101. PubMed ID: 15778453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repression of transcriptional activity of C/EBPalpha by E2F-dimerization partner complexes.
    Zaragoza K; Bégay V; Schuetz A; Heinemann U; Leutz A
    Mol Cell Biol; 2010 May; 30(9):2293-304. PubMed ID: 20176812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The transcription elongation factor CA150 interacts with RNA polymerase II and the pre-mRNA splicing factor SF1.
    Goldstrohm AC; Albrecht TR; Suñé C; Bedford MT; Garcia-Blanco MA
    Mol Cell Biol; 2001 Nov; 21(22):7617-28. PubMed ID: 11604498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the Xenopus laevis CCAAT-enhancer binding protein alpha gene promoter demonstrates species-specific differences in the mechanisms for both auto-activation and regulation by Sp1.
    Kockar FT; Foka P; Hughes TR; Kousteni S; Ramji DP
    Nucleic Acids Res; 2001 Jan; 29(2):362-72. PubMed ID: 11139605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tumour necrosis factor-alpha-mediated suppression of the CCAAT/enhancer binding protein-alpha gene transcription in hepatocytes involves inhibition of autoregulation.
    Foka P; Singh NN; Salter RC; Ramji DP
    Int J Biochem Cell Biol; 2009 May; 41(5):1189-97. PubMed ID: 19027873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell cycle arrest by Kaposi's sarcoma-associated herpesvirus replication-associated protein is mediated at both the transcriptional and posttranslational levels by binding to CCAAT/enhancer-binding protein alpha and p21(CIP-1).
    Wu FY; Wang SE; Tang QQ; Fujimuro M; Chiou CJ; Zheng Q; Chen H; Hayward SD; Lane MD; Hayward GS
    J Virol; 2003 Aug; 77(16):8893-914. PubMed ID: 12885907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HDAC3 interacts with sumoylated C/EBPα to negatively regulate the LXRα expression in rat hepatocytes.
    Ren J; Li D; Li Y; Lan X; Zheng J; Wang X; Ma J; Lu S
    Mol Cell Endocrinol; 2013 Jul; 374(1-2):35-45. PubMed ID: 23639777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two CCAAT/enhancer binding protein sites in the cytochrome P4503A1 locus. Potential role in the glucocorticoid response.
    Rodrigues E; Vilarem MJ; Ribeiro V; Maurel P; Lechner MC
    Eur J Biochem; 2003 Feb; 270(3):556-64. PubMed ID: 12542705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.